sunnyside health tirzepatide for Medical Weight Loss in Los Angeles, CA Tirzepatide Weight Loss Program with

Once-daily tablet

Evidence Snapshot The STEP trials demonstrated significant weight reduction with semaglutide, with gastrointestinal side effects most prominent during dose escalation. Long-term micronutrient outcomes were not primary endpoints

They work the same way in the body and offer a needle-free alternative for many people

Research models would need to mimic these administration routes and consider scaling doses appropriately based on species-specific pharmacokinetic data

Novo Nordisk has added ileus to the Postmarketing Experience section of the Wegovy label under Gastrointestinal Disorders. In October 2025, Severe Gastrointestinal Adverse Reactions was added to the WARNING AND PRECAUTIONS section of the label